Literature DB >> 2400946

Phase I trial of PALA, methotrexate, fluorouracil, leucovorin, and uridine rescue in patients with advanced cancer. The use of uridine to decrease fluorouracil toxicity.

N E Kemeny1, A Schneider, D S Martin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2400946     DOI: 10.3109/07357909009017578

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  1 in total

1.  Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer--a phase II study.

Authors:  Shannon K Tomlinson; Susan A Melin; Vetta Higgs; Douglas R White; Paul Savage; Douglas Case; A William Blackstock
Journal:  BMC Cancer       Date:  2002-05-02       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.